Oruka Therapeutics, Inc. logo ORKA - Oruka Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $153.25 DETAILS
HIGH: $200.00
LOW: $120.00
MEDIAN: $155.50
CONSENSUS: $153.25
UPSIDE: 81.58%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 22.37
Quick Ratio 22.37
Solvency Ratio -6.313
Cash Ratio 3.05

Valuation Ratios

Ratio Value
Price/Earnings
-13.12
Peers avg: 22.7
PEG Ratio 0.24
Forward PEG 0.24
Price/Book 2.93
Price/Sales 0.00
Price/FCF -15.64
Price/Op Cash Flow -15.67

Debt Ratios

Ratio Value
Debt/Assets 0.0040
Debt/Equity 0.0041
Debt/Capital 0.0041
Long-Term Debt/Capital 0.0000
Financial Leverage 1.04

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -5.738
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage -170.19
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -142.50
Operating Cash Flow Coverage -45.66
Capital Expenditure Coverage -422.06
Dividend + Capital Expenditure Coverage -422.06

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.311
Debt/Share 0.0424
Cash/Share 7.39
Book Value/Share 10.35
Tangible BV/Share 10.35
Equity/Share 10.35
Operating Cash Flow/Share -1.934
Capital Expenditure/Share 0.005
FCF/Share -1.938

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.864
Price/Fair Value 2.93
Debt/Market Cap 0.0004
Effective Tax Rate 0.0%
Enterprise Value Multiple -12.70